VEXTF
Vext Science, Inc.
OTC Markets OTCQXUSDEQUITY
DELAYED
Last price
0.21
▲ 0.01 (4.25%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.21
Prev close
0.20
Day high
0.22
Day low
0.21
Volume
12.00K
Market cap
—
P/E (TTM)
—
52W range
0.10 – 0.32
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+4.93%
+6.3%
1M
+20.03%
+16.3%
3M
+2.26%
-0.8%
6M
+7.14%
-3.9%
YTD
+9.74%
-2.6%
1Y
+6.65%
-13.3%
3Y
+39.00%
-35.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $51.37M | $36.00M | $34.81M | $35.41M | — | +42.7% |
| Operating revenue | $51.37M | $36.00M | $34.81M | $35.41M | — | +42.7% |
| Cost of revenue | $36.91M | $27.02M | $22.77M | $12.31M | — | +36.6% |
| Gross profit | $14.46M | $8.98M | $12.04M | $23.10M | — | +61.0% |
| Research & development | — | — | — | — | $150.06K | — |
| Selling, general & admin | $14.91M | $14.29M | $13.84M | $9.82M | — | +4.4% |
| Total operating expense | $21.40M | $20.16M | $19.88M | $13.82M | — | +6.1% |
| Operating income | -$6.94M | -$11.18M | -$7.84M | $9.28M | — | +37.9% |
| Net interest income | -$4.30M | -$3.71M | -$3.64M | -$1.94M | — | -16.0% |
| Pre-tax income | -$15.21M | -$21.12M | $3.36M | $6.70M | — | +28.0% |
| Tax provision | $2.78M | $1.31M | -$1.04M | -$4.22M | — | +111.7% |
| Net income | -$17.99M | -$22.43M | $4.40M | $10.92M | — | +19.8% |
| Net income to common | -$17.99M | -$22.43M | $4.40M | $10.92M | — | +19.8% |
| Basic EPS | -0.07 | -0.08 | 0.03 | 0.08 | — | +12.5% |
| Diluted EPS | -0.07 | -0.08 | 0.03 | 0.08 | — | +12.5% |
| EBIT | -$10.74M | -$17.20M | $7.17M | $8.75M | — | +37.6% |
| EBITDA | $5.14M | -$2.02M | $16.77M | $15.18M | — | +354.5% |
| Basic shares | 247.59M | 240.91M | 164.48M | 138.85M | — | +2.8% |
| Diluted shares | 247.59M | 240.91M | 164.74M | 139.53M | — | +2.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.08M | $4.63M | $8.72M | $5.93M | +9.9% |
| Cash & short-term investments | $5.08M | $4.63M | $8.72M | $5.93M | +9.9% |
| Accounts receivable | $1.23M | $875.00K | $1.26M | $3.12M | +40.7% |
| Inventory | $7.47M | $13.32M | $13.26M | $13.76M | -43.9% |
| Total current assets | $16.78M | $20.81M | $35.93M | $51.93M | -19.3% |
| Property, plant & equipment | $38.55M | $39.47M | $41.17M | $36.45M | -2.3% |
| Goodwill & intangibles | $65.19M | $69.40M | $64.06M | $28.30M | -6.1% |
| Total assets | $120.53M | $136.97M | $149.56M | $120.52M | -12.0% |
| Total current liabilities | $28.49M | $20.28M | $16.40M | $15.73M | +40.5% |
| Current debt | $7.50M | $4.64M | $5.79M | $5.80M | +61.5% |
| Long-term debt | $23.51M | $31.08M | $30.05M | $31.46M | -24.4% |
| Total debt | $35.03M | $39.52M | $38.60M | $38.15M | -11.3% |
| Total liabilities | $65.16M | $63.65M | $56.99M | $48.60M | +2.4% |
| Retained earnings | -$5.12M | $12.87M | $35.31M | $33.32M | -139.8% |
| Shareholder equity | $55.37M | $73.32M | $92.57M | $71.92M | -24.5% |
| Working capital | -$11.71M | $532.00K | $19.54M | $36.19M | -2,301.1% |
| Net tangible assets | -$9.82M | $3.92M | $28.51M | $43.62M | -350.3% |
| Shares issued | 247.68M | 247.44M | 217.48M | 148.96M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$17.99M | -$22.43M | $4.40M | $10.92M | +19.8% |
| Depreciation & amortisation | $15.88M | $15.18M | $9.59M | $6.43M | +4.6% |
| Stock-based compensation | $47.00K | $696.00K | $384.61K | $1.45M | -93.2% |
| Change in working capital | $8.27M | -$1.43M | $4.40M | -$7.27M | +678.1% |
| Operating cash flow | $11.71M | $3.29M | $4.42M | $5.72M | +256.1% |
| Capital expenditure | -$3.57M | -$1.47M | -$2.74M | -$8.86M | -143.5% |
| Investing cash flow | -$5.66M | -$5.44M | -$4.82M | -$30.31M | -4.0% |
| Financing cash flow | -$5.60M | -$1.95M | $3.19M | $24.06M | -187.5% |
| Free cash flow | $8.14M | $1.82M | $1.69M | -$3.14M | +346.5% |
| End cash position | $5.08M | $4.63M | $8.72M | $5.93M | +9.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $12.16M | $13.73M | $12.67M | $13.41M | $11.56M | -11.4% |
| Operating revenue | $12.16M | $13.73M | $12.67M | $13.41M | $11.56M | -11.4% |
| Cost of revenue | $6.64M | $10.39M | $8.70M | $8.54M | $9.28M | -36.2% |
| Gross profit | $5.52M | $3.33M | $3.97M | $4.87M | $2.28M | +65.7% |
| Selling, general & admin | $4.11M | $6.72M | $3.04M | $2.89M | $3.03M | -38.8% |
| Total operating expense | $5.52M | $6.19M | $5.44M | $5.35M | $4.31M | -10.8% |
| Operating income | $0 | -$2.86M | -$1.47M | -$477.00K | -$2.03M | +100.0% |
| Net interest income | -$810.00K | -$2.00M | -$693.00K | -$889.00K | -$832.00K | +59.5% |
| Pre-tax income | -$643.00K | -$9.05M | -$2.87M | $264.00K | -$3.56M | +92.9% |
| Tax provision | $249.00K | $1.50M | -$243.00K | $1.74M | -$223.00K | -83.4% |
| Net income | -$892.00K | -$10.56M | -$2.63M | -$1.48M | -$3.33M | +91.6% |
| Net income to common | -$892.00K | -$10.56M | -$2.63M | -$1.48M | -$3.33M | +91.6% |
| Basic EPS | 0.00 | — | -0.01 | -0.01 | -0.01 | — |
| Diluted EPS | 0.00 | — | -0.01 | -0.01 | -0.01 | — |
| EBIT | $200.00K | -$7.01M | -$2.14M | $1.20M | -$2.62M | +102.9% |
| EBITDA | $4.18M | -$3.00M | $1.87M | $5.30M | $1.12M | +239.5% |
| Basic shares | 24.77M | — | 247.62M | 247.58M | 247.49M | — |
| Diluted shares | 24.77M | — | 247.62M | 247.58M | 247.49M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.54M | $5.08M | $3.70M | $4.55M | $4.83M | +9.0% |
| Cash & short-term investments | $5.54M | $5.08M | $3.70M | $4.55M | $4.83M | +9.0% |
| Accounts receivable | $269.00K | $1.23M | $1.43M | $1.36M | $1.55M | -78.1% |
| Inventory | $8.57M | $7.47M | $9.62M | $10.25M | $10.39M | +14.8% |
| Total current assets | $17.00M | $16.78M | $16.30M | $17.81M | $23.68M | +1.3% |
| Property, plant & equipment | $36.95M | $38.55M | $38.81M | $40.18M | $38.29M | -4.2% |
| Goodwill & intangibles | $63.23M | $65.19M | $71.61M | $73.54M | $67.55M | -3.0% |
| Total assets | $117.18M | $120.53M | $128.09M | $132.88M | $130.86M | -2.8% |
| Total current liabilities | $27.32M | $28.49M | $17.25M | $18.99M | $16.02M | -4.1% |
| Current debt | $7.42M | $7.50M | $2.12M | $2.41M | $3.36M | -1.0% |
| Long-term debt | $22.72M | $23.51M | $29.65M | $29.31M | $30.50M | -3.4% |
| Total debt | $33.97M | $35.03M | $35.06M | $35.62M | $37.36M | -3.0% |
| Total liabilities | $62.69M | $65.16M | $59.68M | $61.84M | $58.37M | -3.8% |
| Retained earnings | -$6.01M | -$5.12M | $7.85M | $10.47M | $11.95M | -17.4% |
| Shareholder equity | $54.49M | $55.37M | $68.41M | $71.04M | $72.49M | -1.6% |
| Working capital | -$10.32M | -$11.71M | -$944.00K | -$1.18M | $7.66M | +11.9% |
| Net tangible assets | -$8.74M | -$9.82M | -$3.20M | -$2.50M | $4.95M | +11.0% |
| Shares issued | 247.68M | 247.68M | 247.68M | 247.58M | 247.58M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$892.00K | -$10.56M | -$2.63M | -$1.48M | -$3.33M | +91.6% |
| Depreciation & amortisation | $3.98M | $4.02M | $4.01M | $4.11M | $3.74M | -1.0% |
| Stock-based compensation | $7.00K | -$5.00K | $10.00K | $17.00K | $25.00K | +240.0% |
| Change in working capital | -$62.00K | $7.18M | $468.00K | $561.00K | $60.00K | -100.9% |
| Operating cash flow | $1.61M | $3.20M | $1.26M | $4.17M | $3.08M | -49.5% |
| Capital expenditure | -$420.00K | -$850.00K | -$1.12M | -$780.00K | -$814.00K | +50.6% |
| Investing cash flow | -$420.00K | -$784.00K | -$1.10M | -$3.08M | -$691.00K | +46.4% |
| Financing cash flow | -$736.00K | -$1.03M | -$1.00M | -$1.37M | -$2.19M | +28.6% |
| Free cash flow | $1.20M | $2.35M | $136.00K | $3.40M | $2.27M | -49.1% |
| End cash position | $5.54M | $5.08M | $3.70M | $4.55M | $4.83M | +9.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.20
+5.77% from price
SMA 20
0.19
+11.89% from price
SMA 50
0.18
+15.69% from price
SMA 100
0.19
+7.92% from price
SMA 200
0.19
+9.46% from price
EMA 12
0.20
+5.86% from price
EMA 26
0.19
+10.48% from price
EMA 50
0.19
+11.86% from price
RSI (14)
61.7
Neutral
MACD (12,26,9)
0.01
Hist 0.00
ATR (14)
0.01
3.38% of price
Realised vol 30D
69.6%
Annualised
Bollinger upper
0.21
20, 2σ
Bollinger lower
0.16
20, 2σ
50 / 200 cross
Death
0.18 vs 0.19
Trend bias
Above 200
+9.46%
Risk profile
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
69.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-45.5%
Peak to trough
Max drawdown 5Y
-89.4%
Peak to trough
ATR 14
0.01
3.38% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Vext Science Inc (VEXTF) (Q2 2026) Earnings Call Highlights: Margin Expansion and Strategic ...
GuruFocus.com · 22h ago
Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter
TMX Newsfile · 2d ago
Vext Announces Date for Q2 2026 Financial Results Release
TMX Newsfile · 10d ago
Vext Opens Sixth Ohio Dispensary in Fairfield
TMX Newsfile · 82d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.